Login
Home / 007570.KS : KSC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Ilyang Pharmaceutical Co.,Ltd

₩7910 -$5140.00 (-39.39%)
KSC · 15 Sep 2026 06:30 UTC
Previous Close
₩7980
Day Range
₩7800₩8000
Year Range
₩7290₩16240
Market Cap
141.79B
AVG Volume
63.9K
Trailing/Forward PE
7.82/16.55
PEG ratio
2.8
Dividend Yield
1.96%
Next Earnings Date
-
Primary Exchange
Korea ExchangeKR
Revenue (KRW)
025B50B75B100B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (KRW)
-10B010B20B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (KRW)
-10B-5B05B10B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (KRW)
-40B-20B020B40B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (KRW)
-40B-20B020B40B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (KRW)
-5000500100024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (KRW)
-50B050B100BR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (KRW)
050B100B150BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
-10010203024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
-400%-200%0%200%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
-2.5%0%2.5%5%7.5%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
05M10M15M20M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (KRW)
050100150200Mar 13Mar 14Dec 16Dec 19Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25
Book Value Per Share (KRW)
0500010000150002000024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (KRW)
0200B400B600B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
0200400600med 20.81Mar 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Free Cash Flow Yield
-20%0%20%40%med -13.92%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Sales
0.40.60.811.2med 0.85Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EV/EBITDA
020406080100med 16.25Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
020406080med 12.69Mar 24Jul 24Oct 24May 25Feb 26Jun 26Sep 26
Price to Book
0.40.60.811.2med 0.94Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Ilyang Pharmaceutical Co.,Ltd
007570.KS
Stockpicker

Video analysis: 007570.KS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.